13G/A filed by Paradigm Biocapital Advisors LP
Paradigm Biocapital Advisors LP and 3 other reporting persons reported 8,257,672 VRDN shares, 7.3% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 21:12:00 UTC.
- Accession
- 0001104659-26-128315
- Filer
- CIK 1855655
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Stake
- Shares
- 8,257,672
- Percent of class
- 7.3%
- Event date
- 2026-09-30
How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.
Read for the filer group Paradigm Biocapital Advisors LP.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| Paradigm BioCapital Advisors LP | PN | 8,257,672 | 0 | 8,257,672 | 0 | 8,257,672 | 7.3% |
| Paradigm BioCapital Advisors GP LLC | OO | 8,257,672 | 0 | 8,257,672 | 0 | 8,257,672 | 7.3% |
| Senai Asefaw, M.D. | IN | 8,257,672 | 0 | 8,257,672 | 0 | 8,257,672 | 7.3% |
| Paradigm BioCapital International Fund Ltd. | CO | 7,278,105 | 0 | 7,278,105 | 0 | 7,278,105 | 6.4% |